N Engl J Med 373:22472257 Marso SP, Daniels GH, Brown-Frandsen K et al (2016) Liraglutide and cardiovascular outcomes in type 2 diabetes
Hypertension, atherosclerosis, endothelial dysfunction, atrial fibrillation, sleep apnea, and vascular inflammation can all influence cognitive risk
These findings indicate a great potential of the dual-targeting strategy (Kou et al., 2017)
For more information, read the What else do I need to know? section below
Critical revision of the manuscript for important intellectual content: all authors
BEST SEMAGLUTIDE WEIGHT LOSS INJECTION in Brooklyn, NY What is Semaglutide